InsurTech: Sky-high private InsurTech valuations are beginning to normalize, on the heels of companies like Kin and TypTap pulling back on their planned public market debuts.
InsurTech: Sky-high private InsurTech valuations are beginning to normalize, on the heels of companies like Kin and TypTap pulling back on their planned public market debuts.